The purpose of this study is to assess the effectiveness of dioxin on prohibiting prostate
cancer progression as measured by PSADT (prostate-specific antigen doubling time).
Phase:
Phase 2
Details
Lead Sponsor:
Sidney Kimmel Cancer Center at Thomas Jefferson University